It's been a strange week for Alzheimer's patients, with both good and bad news from two different studies.
An
abandoned drug rescued from the scrapheap has provided the best results
yet of any drug against the disease, and is also the first to continue
improving symptoms of patients the longer they take it.
Developed
as an antihistamine in Russia and newly tested for a year on 120
Alzheimer's patients, the drug Dimebon raised standard scores of
practical cognitive abilities to almost 7 points above those receiving
placebo, a relatively large difference on a 70-point scale. Read More...